comparative effectiveness research


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia, Wikipedia.

comparative effectiveness research

Any head-to-head study of alternative solutions to managing a disease, esp. when such a study examines a broadly representative population of patients and follows them for a long enough time to determine meaningful outcomes. Its goal is to identify which treatment produces the best clinical outcomes for most patients, rather than which is better than a placebo or which influences a laboratory test or other surrogate marker without having an impact on the actual health or longevity of patients.
See also: research
Mentioned in ?
References in periodicals archive ?
Q: Why is comparative effectiveness research needed?
The ability to gather timely, accurate and comprehensive patient, clinical, claims and outcome data is fundamental to comparative effectiveness research (CER) and ultimately EBM.
The medical device sessions will address various topics, including: the wise use of electronic medical records; strategies for weathering the economy; comparative effectiveness research and its implications; reimbursement in the shadow of healthcare reform; creative funding options; combination devices; and new active implantables beyond the pacemaker.
Comparative effectiveness research (CER), a type of research that evaluates drugs, technologies, and treatment options through decision analysis methodologies, has been a focal point of healthcare reform policy.
Comparative effectiveness research examines clinical outcomes, or the clinical effectiveness, of alternative therapies for the same condition.
Policymaker interest in expanding comparative effectiveness research is encouraging, but we need to ask some hard questions about what we mean by comparative effectiveness research and how it would be implemented.
In addition to comparative effectiveness reviews, the Effective Health Care Program has supported methodological research that will help advance the quality of comparative effectiveness research.
Epstein was Chief R&D Officer and President of Medco-UBC, a 2,400 person global research organization focused on conducting personalized medicine, health economics, drug safety, outcomes, and comparative effectiveness research on behalf of the biopharmaceutical, medical device, and diagnostics industries.
We're hoping to solicit studies that can gather the amounts of data needed to conduct comparative effectiveness research studies and produce useful information about how to better care for people with these conditions.
PACE aims to perform comparative effectiveness research concerning palliative care in long term care facilities (LTCFs) in Europe.
based New England Healthcare Institute (NEHI) recently released an issue brief, "From Evidence to Practice: Making CER Findings Work for Providers and Patients," which detailed the hurdles and policy choices facing leaders in comparative effectiveness research, in their efforts to widely disseminate comparative effectiveness research (CER) findings.

Full browser ?